Research Topics
Species | Camilo JimenezSummaryAffiliation: The University of Texas Country: USA Publications
| Collaborators
|
Detail Information
Publications
Treatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomasMontserrat Ayala-Ramirez
Department of Endocrine Neoplasia and Hormonal Disorders, Unit 1461, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA
J Clin Endocrinol Metab 97:4040-50. 2012..Patients with progressive metastatic pheochromocytomas (PHEOs) or sympathetic paragangliomas (SPGLs) face a dismal prognosis. Current systemic therapies are limited...
An unusual cause of alveolar hemorrhage post hematopoietic stem cell transplantation: a case reportSachin Gupta
Department of Pulmonary Medicine, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
BMC Cancer 6:87. 2006..Diffuse alveolar hemorrhage associated with Strongyloides stercoralis hyperinfection in stem cell transplant patients has been rarely reported...- Inhibition of growth hormone receptor activation by pegvisomant may increase bone density in acromegalyC Jimenez
Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Horm Metab Res 43:55-61. 2011..016) and significant increases in the right hip BMD from baseline to 18 months (p=0.032). The range of the increases was 4.3-17.8% at 7 years. It is concluded that successful treatment of acromegaly with pegvisomant increases BMD... - Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumorsCamilo Jimenez
Department of Endocrine Neoplasia and Hormonal Disorders, Unit 435, The University of Texas M D Anderson Cancer, Center, Houston, Texas 77030, USA
J Clin Endocrinol Metab 94:386-91. 2009..von Hippel-Lindau disease is characterized by highly vascularized tumors of multiple organs... - Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas: insights from the largest single-institutional experienceMontserrat Ayala-Ramirez
Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 118:2804-12. 2012.... - Posterior retroperitoneoscopic adrenalectomy is a safe and effective alternative to transabdominal laparoscopic adrenalectomy for pheochromocytomaPaxton V Dickson
Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
Surgery 150:452-8. 2011..Posterior retroperitoneoscopic adrenalectomy (PRA) is an alternative minimally invasive technique; however, there is a lack of data regarding the appropriateness of this approach in patients with PHEO... - Greater than age-predicted functional deficits in older patients with primary hyperparathyroidismG Stephen Morris
Department of Rehabilitation Services, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
Endocr Pract 18:450-5. 2012..To compare the functional capacity of "asymptomatic" patients with primary hyperparathyroidism (PHPT) with normative values of healthy age-matched subjects... - Posterior retroperitoneoscopic adrenalectomy: a contemporary American experiencePaxton V Dickson
Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA
J Am Coll Surg 212:659-65; discussion 665-7. 2011..The operation requires that surgeons learn a new approach with few similarities to anterior adrenalectomy. This study reports a large series of PRAs incorporated into surgical care using a team-model approach... - Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutationSina Jasim
Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas M D Anderson Cancer Center, Houston, TX, USA
Thyroid 21:189-92. 2011..Further characterization of the clinical behavior of RET-A883F mutation is warranted. We present the clinical data for a family with MEN-2B associated with RET-A883F mutation... - Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicatorsMontserrat Ayala-Ramirez
Department of Endocrine Neoplasia and Hormonal Disorders, Unit 1461, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, Texas 77030, USA
J Clin Endocrinol Metab 96:717-25. 2011..Pheochromocytomas and sympathetic paragangliomas are rare neuroendocrine tumors for which no precise histological or molecular markers have been identified to differentiate benign from malignant tumors... - A novel von Hippel-Lindau point mutation presents as apparently sporadic pheochromocytomaThereasa A Rich
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030 4009, USA
Cancer Invest 26:642-6. 2008..The nearly asymptomatic patient's father also carries the same mutation. Similar to other mutations localized in the same codon, the Gly104Val VHL mutation seems to have an attenuated disease phenotype... - Fatal hypoglycemia in malignant pheochromocytoma: direct glucose consumption as suggested by (18)F-2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography imagingMouhammed Amir Habra
Department of Endocrine Neoplasia and Hormonal Disorders, Unit 1461, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
Endocrine 37:209-12. 2010..Nuclear medicine imaging techniques can illustrate the pathophysiology of hypoglycemia in such cases... - Parathyroidectomy improves functional capacity in "asymptomatic" older patients with primary hyperparathyroidism: a randomized control trialG Stephen Morris
Department of Rehabilitation Services, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Ann Surg 251:832-7. 2010.... - A retrospective cohort analysis of the efficacy of adjuvant radiotherapy after primary surgical resection in patients with adrenocortical carcinomaMouhammed Amir Habra
Department of Endocrine Neoplasia and Hormonal Disorders, Unit 1461, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA
J Clin Endocrinol Metab 98:192-7. 2013..Adrenocortical carcinoma (ACC) is a rare malignancy with high recurrence and mortality rates. The role of adjuvant radiation therapy (RT) to improve outcome remains unclear... - Paraganglioma syndrome type 1 in a patient with Carney-Stratakis syndromeMontserrat Ayala-Ramirez
Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1461, Houston, TX 77030, USA
Nat Rev Endocrinol 6:110-5. 2010..The patient underwent surgery, which confirmed a malignant neck paraganglioma with metastasis to a cervical lymph node. He had no family history of carotid body tumors or pheochromocytoma... - Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion: the University of Texas MD Anderson Cancer Center ExperienceShamim Ejaz
Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Cancer 117:4381-9. 2011..In this report, the authors have described their experience with CS-EAS at The University of Texas MD Anderson Cancer Center to further enhance the current understanding and management of this syndrome... - The noninvestigational use of tyrosine kinase inhibitors in thyroid cancer: establishing a standard for patient safety and monitoringAubrey A Carhill
Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, Baylor College of Medicine, Houston, Texas 77030, USA
J Clin Endocrinol Metab 98:31-42. 2013.... - Preoperative serum osteocalcin may predict postoperative elevated parathyroid hormone in patients with primary hyperparathyroidismNahid Rianon
Department of Family and Community Medicine, University of Texas Medical School at Houston, 6431 Fannin Street JJL324, Houston, TX 77030, USA
World J Surg 36:1320-6. 2012..Predicting which patients may need treatment is difficult. This study investigated whether preoperative serum osteocalcin (OC), a bone turnover marker involved in mineralization, can predict POePTH... - A novel SDHB mutation associated with hereditary head and neck paragangliomaBrandon W Peck
Department of Medicine, Baylor College of Medicine, Houston, Texas, USA
Laryngoscope 121:2572-5. 2011..To describe a novel germline mutation in the succinate dehydrogenase subunit B (SDHB) gene... - Preoperative vitamin D replacement therapy in primary hyperparathyroidism: safe and beneficial?Elizabeth G Grubbs
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Tex, USA
Surgery 144:852-8; discussion 858-9. 2008..The significance of vitamin D deficiency with primary hyperparathyroidism (PHPT) remains unclear. The safety and value of preoperative vitamin D (Vit D) replacement is unknown... - A catecholamine crisis on Mount Kilimanjaro: a hypoxia effect?Montserrat Ayala-Ramirez
Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
J Travel Med 17:424-6. 2010..We describe an individual with a paraganglioma complicated by a catecholamine crisis that occurred on the summit of Mount Kilimanjaro... - Management of medullary thyroid carcinoma and MEN2 syndromes in childhoodSteven G Waguespack
The Department of Endocrine Neoplasia and Hormonal Disorders, PO Box 301402, Unit 1461, Houston, TX 77230 1402, USA
Nat Rev Endocrinol 7:596-607. 2011..To optimize care and to facilitate ongoing research, children with MTC and the MEN2 syndromes are optimally treated at tertiary centers with multidisciplinary expertise... - Malignant head and neck paragangliomas: is there an optimal treatment strategy?Daniel J Moskovic
Scott Department of Urology, Baylor College of Medicine, Houston, Texas, USA
Head Neck Oncol 2:23. 2010..Little is known about management and prognosis for malignant head & neck paragangliomas. We reviewed records of these patients to determine optimal treatment strategies... 
Expression analysis of fibroblast growth factor-23, matrix extracellular phosphoglycoprotein, secreted frizzled-related protein-4, and fibroblast growth factor-7: identification of fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein aMouhammed Amir Habra
Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Endocr Pract 14:1108-14. 2008..To evaluate the expression of various phosphaturic factors in the tumor of a patient with tumor-induced osteomalacia (TIO) and to analyze serum levels of fibroblast growth factor (FGF)-23 in TIO and healthy subjects...- Skeletal sequelae of cancer and cancer treatmentCharles J Stava
Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas M D Anderson Cancer Center, Unit 1461, 1515 Holcombe Boulevard, Houston, TX 77030, USA
J Cancer Surviv 3:75-88. 2009..Skeletal disorders are often associated with advancing age, but these effects can be exacerbated by exposure to cancer and its treatment. This review will explore the cancer and cancer treatment-related causes of skeletal disorders... - Novel germline SDHD mutation: diagnosis and implications to the patientJeena Varghese
Departments of Endocrine Neoplasia and Hormonal Disorders, Unit 1461, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
Fam Cancer 10:365-71. 2011..His blood pressure normalized and he discontinued antihypertensive medications after surgery. He is currently on replacement therapy with hydrocortisone and fludrocortisone... - Posterior retroperitoneoscopic adrenalectomy: preferred technique for removal of benign tumors and isolated metastasesNancy D Perrier
Department of Surgical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA
Ann Surg 248:666-74. 2008..This anatomically direct approach, popularized by Walz, minimizes dissection and affords early access to the adrenal vein. We report the largest experience to date of PRA in the United States... - Management of medullary thyroid carcinomaCamilo Jimenez
Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Unit 435, 1515 Holcombe Boulevard, Houston, TX 77030 4009, USA
Endocrinol Metab Clin North Am 37:481-96, x-xi. 2008.... - Peer-reviewed, evidence-based analysis of vitamin D and primary hyperparathyroidismStorm Weaver
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, PO Box 301402, Houston, TX 77230 1402, USA
World J Surg 33:2292-302. 2009..New understanding about the effect of vitamin D on parathyroid hormone regulation may provide an opportunity to better understand the coexistence of PHPT and vitamin D deficiency... - Follow-up of pituitary tumor volume in patients with acromegaly treated with pegvisomant in clinical trialsCamilo Jimenez
Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Eur J Endocrinol 159:517-23. 2008..We present details on 9 of 304 patients in clinical trials with pegvisomant who experienced tumor growth within the first year of treatment... - Pheochromocytoma and medullary thyroid carcinoma: a new genotype-phenotype correlation of the RET protooncogene 891 germline mutationCamilo Jimenez
The University of Texas MD Anderson Cancer Center, Department of Endocrine Neoplasia and Hormonal Disorders, 1515 Holcombe Boulevard, Unit 435, Houston, Texas 77030, USA
J Clin Endocrinol Metab 89:4142-5. 2004..These findings indicate that patients with this mutation should be screened for pheochromocytoma... - Random postoperative day-3 cortisol concentration as a predictor of hypothalamic-pituitary-adrenal axis integrity after transsphenoidal surgeryMaryam I Khan
Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas M D Anderson Cancer Center, Houston, Texas, USA
Endocr Pract 17:717-26. 2011..To determine whether a random postoperative day-3 cortisol value of 10 μg/dL or greater is predictive of adrenal sufficiency 3 to 10 weeks after transsphenoidal surgery (TSS) and during long-term clinical follow-up... - Prospective, randomized, controlled trial of parathyroidectomy versus observation in patients with "asymptomatic" primary hyperparathyroidismNancy D Perrier
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77230 1402, USA
Surgery 146:1116-22. 2009..The aim of this study was to determine the impact of parathyroidectomy (PTX) on brain function and sleep in "asymptomatic" PHPT patients... - Benign familial hypocalciuric hypercalcemiaJeena Varghese
Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
Endocr Pract 17:13-7. 2011..To review the pathophysiology, clinical features, diagnosis, and management options for benign familial hypocalciuric hypercalcemia... - Primary hyperparathyroidism and osteosarcoma: examination of a large cohort identifies three cases of fibroblastic osteosarcomaCamilo Jimenez
Department of Endocrinology, Diabetes, and Metabolism, Baylor College of Medicine, Houston, Texas, USA
J Bone Miner Res 20:1562-8. 2005..The finding of fibroblastic osteosarcoma in all three patients raises the question of whether coexistent hyperparathyroidism may modify the cytologic and histologic features of the malignancy... - Bone loss in patients with breast or prostate cancerMimi I Hu
Department of Endocrine Neoplasia, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 435, Houston, TX 77030, USA
Curr Osteoporos Rep 5:170-8. 2007.... - Endocrine sequelae of cancer and cancer treatmentsCharles J Stava
Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas M D Anderson Cancer Center, Unit 435, 1515 Holcombe Boulevard, Houston, TX 77030, USA
J Cancer Surviv 1:261-74. 2007..This review will explore the endocrinologic adverse effects from non-endocrine cancer therapies... - A novel nomenclature to classify parathyroid adenomasNancy D Perrier
Department of Surgical Oncology, Unit 444, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
World J Surg 33:412-6. 2009..We developed a nomenclature that provides a precise means of communicating the most frequently encountered parathyroid adenoma locations... - Parathyroid carcinoma: a 22-year experienceNaifa L Busaidy
joint Baylor College of Medicine/The University of Texas M. D. Anderson Cancer Center Training Program in Endocrinology, Diabetes, and Metabolism, Houston, Texas, USA
Head Neck 26:716-26. 2004..A comprehensive multidisciplinary approach with surgery, radiation therapy, and medical treatment for hypercalcemia is needed to optimize patient outcome...